Prospective, observational, non-interventional, comparative, multicenter RIPH3 study to investigate the impact of HTSH on length of hospital stay in referring services.
Patient selection criteria
Patient male or female at least 60 years of age, as initially defined with the Regional Health Agency, discharged from hospital,
Oral expression of non opposition to participation in the study, documented in the medical record by the physician,
Presenting a defined and feasible plan for returning home,
None
258 subjects in the prospective group. Retrospective data will be collected directly from hospital departments by ARS IDF or from physicians responsible for medical information (RMI) within each hospital center participating in the study, for the 2 years 2021 and 2022 prior to the study and compared with the average length of stay for services to be calculated at the end of the study.
Other
Prospective
Not listed
Study to investigate the impact of HTSH on length of hospital stay in referring services
The main assessment criterion is based on the average length of stay observed at the end of the study, compared with that of the previous two years, 2021 and 2022, in the referring services.
Analysis of pathways and plans for returning home
Evaluation criteria: Calculation of the proportion of patients in the life project on admission to nursing home / long term care units and the return home at the end of the stay.
Analysis of HTSH patient profiles a) Proportion of eligible patients and their comorbidities b) Social profile + main reason for hospitalization of patients admitted to HTSH
Evaluation criteria: Ratio of hospital ward activity data to pre-screening data collected during the study.
Analysis of discharges and patient outcomes
Proportion of patients remaining at home in the medium term Patients' functional outcome after the trial
Quality of life and caregiver benefit analysis
Quality of life assessment
